From 7 to 9 March 2017, CSL Behring in Bern, Switzerland hosted the First Intercontinental Immunoglobulin and Hereditary Angioedema Academy.
The conference included presentations from 13 international immunodeficiency and HAE specialists, as well as a plant tour at CSL Behring AG. During the meeting, the approximately 90 immunologists from all over the world enjoyed a unique opportunity to increase their knowledge about the pathophysiology and the clinical management of immunodeficiencies and HAE.
“This event is an important proof point that CSL Behring is a worldwide strategic partner in developing educational programs for physicians. We are very much looking forward to contributing to the cooperation and networking among these Health Care Providers,” said Lucilla Franchetta Ortelli, Senior Product Manager.
(Source: CSL Behring)
